Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01160783 · ClinicalTrials.gov registry record
Genetic Contributions to Autism Spectrum Disorders
A clinical trial of Autism Spectrum Disorder and Autism, sponsored by Boston Children's Hospital.
- Active
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT01160783: Active study of Autism Spectrum Disorder and Autism, sponsored by Boston Children's Hospital.
NCT01160783 is a study of Autism Spectrum Disorder and Autism that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 240 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01160783, a study of Autism Spectrum Disorder and Autism, is active but no longer recruiting, sponsored by Boston Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is working towards gaining a better understanding of the genetic and environmental factors involved in autism spectrum disorders (ASD), which includes autism, pervasive developmental disorder (PDD), and Asperger's syndrome. The investigators hope that information gained from this study will lead to new ways of diagnosing and treating ASDs.
Primary Outcome
Gene expression levels
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2007-04 |
| Est. Completion | 2028-02 |
What the registry record for NCT01160783 still lists
NCT01160783 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (79% higher).
The record links to 4 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT01160783 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01160783 about?
NCT01160783 is a clinical study titled "Genetic Contributions to Autism Spectrum Disorders". This study is working towards gaining a better understanding of the genetic and environmental factors involved in autism spectrum disorders (ASD), which includes autism, pervasive developmental disorder (PDD), and Asperger's syndrome. The investigators hope that information gained from this study wi...
What is the current status of trial NCT01160783?
This trial is currently active not recruiting. The enrollment target is 240 participants. The study started on 2007-04. Estimated completion is 2028-02.
What conditions does trial NCT01160783 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Pervasive Developmental Disorder, Asperger's Syndrome.
Who is sponsoring clinical trial NCT01160783?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01160783 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01160783's enrollment target sits among peer trials
240 33rd of 224 higher than 191 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia